Skip to main content

Table 1 Comparison of SLE patients to healthy controls

From: Prevalence of cardiac morphological and functional alterations in systemic lupus erythematosus patients with a low disease activity

  SLE patients (n=29) Healthy controls (n=30)  
LV EF (%) 64.1±9.4 68.4±5.4 p<0.05
LV EDV (ml) 152.7±31.0 129.1±30.9 p<0.01
LV ESV (ml) 56.3±24.3 41.7±16.0 p<0.01
LV SV (ml) 96.5±19.5 87.3±16.8 p=n.s.
LV Cardiac output (l/min) 7.0±1.9 6.1±1.2 p<0.05
MAPSE (mm) 12.9±2.7 14.6±4.1 p=n.s.
LV EDV/BSA (ml/m2) 85.7±17.5 73.6±14.2 p<0.01
LV ESV/BSA (ml/m2) 31.8±15.2 23.8±8.3 p<0.05
LV SV/BSA (ml/m2) 53.9±9.6 49.8±7.0 p=n.s.
RV EF (%) 52.9±9.0 60.2±7.4 p<0.01
RV EDV (ml) 178.0±29.5 127.1±34.6 p<0.0001
RV ESV (ml) 83.8±20.6 50.8±17.3 p<0.0001
RV SV (ml) 94.2±24.0 76.3±21.2 p<0.01
RV Cardiac output (l/min) 6.8±2.1 5.3±1.6 p<0.01
TAPSE (mm) 23.3±6.0 20.1±4.7 p<0.05
RV EDV/BSA (ml/m2) 52.5±11.5 43.5±10.9 p<0.01
RV ESV/BSA (ml/m2) 47.2±12.7 28.9±8.8 p<0.0001
RV SV/BSA (ml/m2) 52.5±11.5 43.5±10.9 p<0.001
Wall mass (g) 73.1±19.2 63.3±20.9 p=n.s.
Wall mass/BSA (g/m2) 40.7±9.0 35.9±9.5 p=n.s.